The silencing of AR in transgenic adenocarcinoma of the mouse prostate (TRAMP) animals, has been reported to support EMT, by reducing Epithelial-cadherin (E-cadherin) expression and increasing vimentin and Neural-cadherin (N-cadherin) expression [35]. This evidence concerns the gene CDH2 and male reproductive organ cancer.